DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
Lung, breast, colorectal, and prostate cancers are the most incident worldwide. Optimal population-based cancer screening methods remain an unmet need, since cancer detection at early stages increases the prospects of successful and curative treatment, leading to a lower incidence of recurrences. Mo...
Main Authors: | Vera Constâncio, Sandra P. Nunes, Rui Henrique, Carmen Jerónimo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/3/624 |
Similar Items
-
Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value
by: Walter Pulverer, et al.
Published: (2021-10-01) -
Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women
by: Sandra P. Nunes, et al.
Published: (2018-09-01) -
Advances in Prognostic Methylation Biomarkers for Prostate Cancer
by: Dilys Lam, et al.
Published: (2020-10-01) -
Evaluating liquid biopsies for methylomic profiling of prostate cancer
by: Romina Silva, et al.
Published: (2020-07-01) -
Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas
by: María Gallardo-Gómez, et al.
Published: (2023-10-01)